Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
---|
04/15/2004 | WO2004020445A3 4-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties |
04/15/2004 | WO2004016607B1 Inhibition of phosphoinositide 3-kinase beta |
04/15/2004 | WO2004005289A3 Efficient synthesis of pyropheophorbide a and its derivatives |
04/15/2004 | WO2003101988A3 Compounds and compositions for the treatment of diabetes and diabetes-related disorders |
04/15/2004 | WO2003067286A3 Nanofilm and membrane compositions |
04/15/2004 | WO2002083111A3 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence |
04/15/2004 | US20040073054 Using a fluorinated phenyl compound containing electrophilic and nucleophilic groups |
04/15/2004 | US20040073036 Substituted alkyl amido piperidines |
04/15/2004 | US20040073033 Process for the preparation of phenylalanine enamide derivatives |
04/15/2004 | US20040073026 Cyclic protein tyrosine kinase inhibitors |
04/15/2004 | US20040072889 Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia |
04/15/2004 | US20040072880 Cycloalkyl inhibitors of potassium channel function |
04/15/2004 | US20040072861 Anxiolytic agents |
04/15/2004 | US20040072859 Urea substituted imidazoquinoline ethers |
04/15/2004 | US20040072858 Heterocyclic ether substituted imidazoquinolines |
04/15/2004 | US20040072853 Therapeutic compounds |
04/15/2004 | US20040072843 Novel sulfonamide substituted chroman derivatives useful as beta 3 adrenoreceptor agonists |
04/15/2004 | US20040072837 Filtration; freeze drying; anticancer agents |
04/15/2004 | US20040072836 Substituted aza-oxindole derivatives |
04/15/2004 | US20040072833 Antidepressants; anxiolytic agents; eating disorders; antiulcer agents; drug abuse; Alzheimer's disease |
04/15/2004 | US20040072831 Reverse-turn mimetics and method relating thereto |
04/15/2004 | US20040072830 Squalene synthetase inhibitors; antilipemic agents; antiischemic agents; cardiovascular disorders; anticholesterol agents |
04/15/2004 | US20040072817 Therapy for bacteria infections |
04/15/2004 | US20040072816 Dysmenorrhea; congestive heart failure; liver disorders; vision defects |
04/15/2004 | DE19948438B4 Bicyclische Imidazo-3-aminderivate Bicyclic imidazo-3-amine derivatives |
04/15/2004 | DE19744257B4 Beta-Carboline und deren Verwendung zur Behandlung von malignen und anderen, auf pathologischen Zellproliferationen beruhenden Erkrankungen Beta-carbolines and their use for the treatment of malignant and other diseases based on pathological cell proliferations |
04/15/2004 | DE10248067A1 New N-diaminophenylpropyl- or N-heteroarylpropyl-piperazine or piperidine derivatives, useful as dopaminergic and/or serotoninergic agents for e.g. treating Parkinson's disease or schizophrenia |
04/15/2004 | CA2501502A1 Pyrazole derivatives |
04/15/2004 | CA2500844A1 Bicyclic heteroaromatic compounds as kinase inhibitors |
04/15/2004 | CA2500727A1 Vasculostatic agents and methods of use thereof |
04/15/2004 | CA2500088A1 Morpholine-bridged indazole derivatives |
04/14/2004 | EP1408040A1 Tricyclic fused heterocyclic compounds as CRFantagonists |
04/14/2004 | EP1408034A1 Use of Quinoline derivatives as antibacterial agents |
04/14/2004 | EP1406908A1 Morpholine-bridged pyrazolopyridine derivatives |
04/14/2004 | EP1406906A1 Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands |
04/14/2004 | EP1406901A1 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease |
04/14/2004 | EP1406900A1 Novel compounds, their preparation and use |
04/14/2004 | EP1406897A2 Compounds |
04/14/2004 | EP1406894A1 Piperazine oxime derivatives having nk-1 receptor antagonistic activity |
04/14/2004 | EP1406696A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease |
04/14/2004 | EP1406632A2 Substituted 3-aryl-5-aryl- 1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof |
04/14/2004 | EP1406631A2 Dopamine receptor ligands and therapeutic methods based thereon |
04/14/2004 | EP1406619A1 Antiviral and antimicrobial guanidine or biguanidine derivatives |
04/14/2004 | EP1280804B1 A process for the preparation of anti-psychotic 3- 2- 4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4h-pyrido 1,2,-a]pyrimidin-4-one |
04/14/2004 | EP1202994B1 New compounds |
04/14/2004 | EP1171440B1 Substituted-3-cyano-[1.7],[1.5], and [1.8]-naphthyridine inhibitors of tyrosine kinases |
04/14/2004 | EP1073655B1 Pharmaceutically available protoberberine salts derivatives, and protoberberine derivatives and salts thereof |
04/14/2004 | EP1042315B1 Cyclic imide-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents |
04/14/2004 | EP0948495B1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents |
04/14/2004 | EP0925298B1 Substituted 6,6-hetero-bicyclic derivatives |
04/14/2004 | EP0921800B1 Substituted biphenyl isoxazole sulfonamides |
04/14/2004 | EP0912565B1 Process for preparing imidazoquinolinamines |
04/14/2004 | CN1489581A 喹唑啉酮衍生物 Quinazolinone derivatives |
04/14/2004 | CN1489579A 7-heterocyclyl quinoline and thieno[2,3,-b] pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
04/14/2004 | CN1489458A Inhibitors against the production and releaseof inflammator cytokines |
04/14/2004 | CN1145614C Irreversible inhibitors of tyrosine kinases, its pharmaceutical use and medicine composition thereof |
04/13/2004 | US6720422 Amide substituted imidazopyridines |
04/13/2004 | US6720341 Preventives/remedies for kidney diseases |
04/13/2004 | US6720339 Such as n-phenyl-4-oxo-6,6-dimethyl-4,5,6,7-tetrahydro-1h-indole-3-carboxamide; for diagnosis and treatment of anxiety, sleep and seizure disorders, overdose with benzodiazepine drugs, and for memory enhancement |
04/13/2004 | US6720334 Immune response modifiers; cytokine biosynthesis; viral and neoplastic diseases; 1-(4-(4-amino-6,7-dimethyl-1h-imidazo (4,5-c)pyridin-1-yl)butyl)-3-phenylurea. |
04/13/2004 | US6720333 Amide substituted imidazopyridines |
04/13/2004 | US6720332 Oxindole derivatives |
04/13/2004 | US6720331 Having anti-mitotic activity for therapy of cancer |
04/13/2004 | US6720324 Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof |
04/13/2004 | US6720317 Inhibitors of factor Xa |
04/13/2004 | US6720188 Monitoring the concentration of arginine in sample; obtain sample, incubate with binding particle, determine arginine concentration in sample |
04/13/2004 | US6719339 Vehicle protection assembly |
04/08/2004 | WO2004029055A1 Fused azole-pyrimidine derivatives |
04/08/2004 | WO2004029053A1 Novel 1,4-diazabicycloalkane derivatives, their preparation and use |
04/08/2004 | WO2004029052A1 Process for preparing haloalkyl pyrimidines |
04/08/2004 | WO2004029051A1 Pyrazole amides for treating hiv infections |
04/08/2004 | WO2004029040A1 3,4-disubstituted pyrroles and their for use in treating inflammatory diseases |
04/08/2004 | WO2004028540A1 Anti-neurodegenerative agents |
04/08/2004 | WO2004028539A2 1h-imidazo dimers |
04/08/2004 | WO2004028459A2 Piperidine derivatives |
04/08/2004 | WO2004016741A3 Prenylation inhibitors containing dimethyl-cyclobutane and methods of their synthesis and use |
04/08/2004 | WO2004016604A3 Azabicyclic compounds are central nervous system active agents |
04/08/2004 | WO2004014893A3 Antimicrobial aza-bicyclic derivates, their compositions and uses |
04/08/2004 | WO2004014361A9 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity |
04/08/2004 | WO2004000205A3 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
04/08/2004 | WO2003086314A3 Tyrosine kinase inhibitors |
04/08/2004 | WO2003082832A3 Anxiolytic agents with reduced sedative and ataxic effects |
04/08/2004 | WO2003057667B1 Strapped and modified bis (benzimidazole) diamides for asymmetric catalysts and other applications |
04/08/2004 | US20040068115 Charge transport compositions and electronic devices made with such compositions |
04/08/2004 | US20040068109 Activated blood coagulation factor X inhibitor and also to such a pharmaceutical agent and particularly has an excellent activity by oral administration |
04/08/2004 | US20040067998 Oral administering |
04/08/2004 | US20040067997 Respiratory syncytial virus |
04/08/2004 | US20040067994 Grampositive, gramnegative bacteria therapy |
04/08/2004 | US20040067976 Compounds useful for treating Hepatitis C virus |
04/08/2004 | US20040067975 Amido ether substituted imidazoquinolines |
04/08/2004 | US20040067974 Alzheimer's disease; Down's syndrome; synergistic mixture containing galanthamine |
04/08/2004 | US20040067964 Antiinflammatory agents |
04/08/2004 | US20040067937 Guanylate cyclase stimulant; cardiovascular disorders; thrombosis; antiischemic agents; sexual disorders; antiinflammatory agents; central nervous system disorders |
04/08/2004 | US20040067930 Central nervous system disorders; neurotransmitters; side effect reduction |
04/08/2004 | US20040067924 Actinium-225 complexes and conjugates for targeted radiotherapy |
04/08/2004 | US20040067852 For plants; fungicides |
04/08/2004 | US20040067531 Methods of modulating protein tyrosine kinase function with substituted indolinone compounds |
04/08/2004 | US20040067256 Novel modified release formulation |
04/08/2004 | US20040067252 Novel modified release formulation |
04/08/2004 | US20040066135 Electronic devices made with electron transport and/or anti-quenching layers |